Christopher Sobey
Christopher Sobey
NHMRC Senior Research Fellow, Professor in Physiology, School of Life Sciences, La Trobe University
Verified email at - Homepage
TitleCited byYear
Apoptotic mechanisms after cerebral ischemia
BRS Broughton, DC Reutens, CG Sobey
Stroke 40 (5), e331-e339, 2009
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
GR Drummond, S Selemidis, KK Griendling, CG Sobey
Nature reviews Drug discovery 10 (6), 453, 2011
Vascular dysfunction in monkeys with diet-induced hyperhomocyst (e) inemia.
SR Lentz, CG Sobey, DJ Piegors, MY Bhopatkar, FM Faraci, MR Malinow, ...
The Journal of clinical investigation 98 (1), 24-29, 1996
Pathophysiology, treatment, and animal and cellular models of human ischemic stroke
TM Woodruff, J Thundyil, SC Tang, CG Sobey, SM Taylor, TV Arumugam
Molecular neurodegeneration 6 (1), 11, 2011
SP Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ...
Br J Pharmacol. 174 (Suppl 1), S1-S16., 2017
Potassium channel function in vascular disease
CG Sobey
Arteriosclerosis, thrombosis, and vascular biology 21 (1), 28-38, 2001
Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE−/− mice
CP Judkins, H Diep, BRS Broughton, AE Mast, EU Hooker, AA Miller, ...
American Journal of Physiology-Heart and Circulatory Physiology 298 (1), H24-H32, 2009
NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition
S Selemidis, CG Sobey, K Wingler, HHHW Schmidt, GR Drummond
Pharmacology & therapeutics 120 (3), 254-291, 2008
Subarachnoid haemorrhage: what happens to the cerebral arteries?
CG Sobey, FM Faraci
Clinical and Experimental Pharmacology and Physiology 25 (11), 867-876, 1998
Mechanisms of Bradykinin-Induced Cerebral Vasodilatation in Rats: Evidence That Reactive Oxygen Species Activate K+ Channels
CG Sobey, DD Heistad, FM Faraci
Stroke 28 (11), 2290-2295, 1997
NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries
AA Miller, GR Drummond, HHHW Schmidt, CG Sobey
Circulation research 97 (10), 1055-1062, 2005
Targeting Rho and Rho-kinase in the treatment of cardiovascular disease
K Budzyn, PD Marley, CG Sobey
Trends in pharmacological sciences 27 (2), 97-104, 2006
Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension
QN Dinh, GR Drummond, CG Sobey, S Chrissobolis
BioMed research international 2014, 2014
Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke
DYW Fann, SY Lee, S Manzanero, SC Tang, M Gelderblom, P Chunduri, ...
Cell death & disease 4 (9), e790, 2013
Evidence that macrophages in atherosclerotic lesions contain angiotensin II
DD Potter, CG Sobey, PK Tompkins, JD Rossen, DD Heistad
Circulation 98 (8), 800-807, 1998
Endothelial NADPH oxidases: which NOX to target in vascular disease?
GR Drummond, CG Sobey
Trends in Endocrinology & Metabolism 25 (9), 452-463, 2014
Oxidative stress and endothelial dysfunction in cerebrovascular disease.
S Chrissobolis, AA Miller, GR Drummond, BK Kemp-Harper, CG Sobey
Frontiers in bioscience (Landmark edition) 16, 1733-1745, 2011
Increased NADPH-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo
TM Paravicini, S Chrissobolis, GR Drummond, CG Sobey
Stroke 35 (2), 584-589, 2004
Adiponectin receptor signalling in the brain
J Thundyil, D Pavlovski, CG Sobey, TV Arumugam
British journal of pharmacology 165 (2), 313-327, 2012
Pathogenesis of acute stroke and the role of inflammasomes
DYW Fann, SY Lee, S Manzanero, P Chunduri, CG Sobey, TV Arumugam
Ageing research reviews 12 (4), 941-966, 2013
The system can't perform the operation now. Try again later.
Articles 1–20